Skip to main contentaccessibility options
PRINT | BOOKMARK | TEXT SIZE A A A

TMRC Achievements

Early Achievements of TMRC 

  • 65 new translational programmes supported in the first two years (£23.3m commitment).
  • Over 220 TMRC-focused staff in place across Scotland.
  • Core laboratory operational (new £10m building opening late-08).
  • Established processes and systems that will underpin success.

 

Some Important Early Outputs

Initial publications submitted to peer-reviewed journals.

 

Scientific abstracts presented at international conferences.

 

Strong pipeline of Intellectual Property opportunities in the diagnostic field, across all the TMRC therapeutic areas - these include:

 

  • Transgenic mouse model for schizophrenia.
  • Analysis software for predicting fracture risk and disease progression in osteoarthritis.
  • Novel antibody-based and qPCR assays of inflammation parameters in asthma.
  • Multiplex genotyping assay for population screening for risk factors associated with cardiovascular disease, diabetes, obesity and metabolic syndrome.
  • Multiplex genetic test for prediction of treatment response and disease progression in colorectal cancer.
  • MS assay and methodology for quantitative measurement of phosphorylation status of a key signalling pathway in human cancers and tumourogenesis.
  • Biomarkers of response to neoadjuvant chemotherapy.
  • Novel biomarkers of endometrial dysfunction.